• Skip to primary navigation
  • Skip to main content
  • Skip to footer

MCN Solutions

  • Solutions
    • For Healthcare
    • Policy Manager
    • Policy Library
    • eLearning
    • StayAlert!
    • StayAlert! Plus
  • About Us
  • Resources
    • Blog
    • Product Sheets
    • E-book
    • Case Studies
    • Videos
    • StayAlert! Login
  • Contact

Schedule a Demo

Site Map

Pages

  • About Us
  • Blog
  • Case Studies
  • Christie Clinic Case Study
  • Contact
  • Contract Manager
  • Disclaimer
  • Download Contract Manager
  • Download eLearning
  • DownLoad Policy Library
  • Download Policy Manager
  • Download StayAlert
  • Download StayAlert Plus
  • E-book
  • eLearning
  • eLearning for Business
  • Emory Case Study
  • For Healthcare
  • HealthAlliance Case Study
  • Home
  • Meritus Medical Center Case Study
  • Our Partners
  • Personal Data Request
  • Policy & Procedure Library
  • Policy Manager
  • Poplar Bluff Case Study
  • Privacy Policy
  • Product Sheets
  • Resources
  • Schedule a Demo
  • StayAlert! Plus
  • StayAlert! Regulatory Notifications
  • Videos
  • Web Accessibility
  • Web-based Learning
  • White Papers

Posts by category

  • Category: Contract Management
    • How to Reduce Risk With Contract and Risk Management
  • Category: Document Management
    • Healthcare Document Management Software
    • Policy Management Software As a Part of Risk Management in Healthcare
  • Category: Education
    • Staff Education as a Business Priority
    • Importance of Continuing Staff Education
    • How Staff Education in Healthcare Drives Excellence
  • Category: General
    • Corporate Compliance and Ethics Week: Why It Matters for Your Organization
  • Category: Healthcare
    • How to Effectively Introduce Nursing Policies to Staff
    • Best Ways to Solve Policy Management Challenges in Healthcare
    • CMS Requirements for Director of Nursing Roles
    • Review of a Hospital’s Diet Orders
    • Risks of Ineffective Policy Management
    • Choosing the Right Policy Management Software for Healthcare
    • Overcoming Challenges in Public Health Policy Implementation
    • Policy Management Challenges and Benefits
    • Enhancing Patient Safety Through Better Care Coordination
    • Medicare Swing Bed Rules and Regulations for CAHs
    • Exploring the Difference Between Nursing Procedures and Policies
    • Nurse Appreciation: The Quiet Heroes We Are Thankful for This Thanksgiving
    • Regulatory Change Management: 5 Essential Tips for Staying Ahead
    • Elevating Patient Safety: The Crucial Role of Policy Management
    • Hero Women Rising: A Chance to Double Your Impact
    • Elevating Patient Safety: The Crucial Role of Policy Management
    • January is Human Trafficking Prevention Month
    • Strategies for Promoting Ethical Behavior in Healthcare Compliance
    • The Role of Healthcare Policy and Procedure Management Software
    • The Essential Components of an Effective Healthcare Compliance Program
    • Navigating Policy Challenges in Healthcare: Centralized Management for Compliance and Efficiency
    • Staying Up-to-Date with Compliance Requirements with Healthcare Policy Management Software
    • Maximizing Efficiency with Contract Management Software
    • How to Utilize Policy Management Software to Improve Quality of Care
    • Effective Strategies for Enhancing Governance, Risk, and Compliance
    • Streamline Your Nursing Policy Review Process for Improved Efficiency
    • Patient Safety Awareness Week
    • How to Effectively Introduce Nursing Policies To Staff
    • Using Nursing Policy Management to Ensure Quality Care
    • Sepsis Survivors Week
    • MCN Healthcare’s Exemplary Customer Experience
    • Hero Women Rising and MCN Foundation
    • A Holistic Approach to Success
    • Exceptional Customer Support Leads to Greater Adoption, Use, and Value of Policy Management Software
    • Policy Management Software Should Make Your Job Easier, Not Harder
    • Why You Need Policy Automation in the First Place
    • National Time Out Day
    • Patient Safety Awareness Week – March 13 – 19, 2022
    • Unit Manager’s Role in the Policy Process
    • Global Handwashing Day – October 15, 2021
    • World Mental Health Day – October 10, 2021
    • Breast Cancer Awareness Month
    • Policies, Protocols, and Guidelines
    • World Patient Safety Day – September 7, 2021
    • World Suicide Prevention Day | September 10, 2021
    • MCN Foundation and Ethiopian Education Foundation Collaborate to Support Students
    • The Impact of Leadership Culture on Achieving Effective Clinical Practice Change
    • World Health Day – April 7, 2021
    • World Antimicrobial Awareness Week November 18-24, 2020
    • Organizational Risk Related to Poor Document Control and Policy Management
    • International Day of the Girl – October 11, 2020
    • October is Breast Cancer Awareness Month
    • September is Sepsis Awareness Month
    • Sepsis – Information for Health Care Professionals
    • Sepsis Heroes Gala
    • September 10th is World Suicide Prevention Day
    • Risk and Policy Management
    • Heroes Health Mental Wellness App
    • StayAlert! to Stay Compliant
    • An Update of Mental Health Initiatives During Mental Health Awareness Month
    • Nurses Make a Difference
    • Heroes
    • New OCR Settlement Highlights Challenges of Implementing COVID-19 Triage Policies
    • Mindfulness in the Midst of a Pandemic
    • Take a Minute to say THANK YOU – World Health Day 2020
    • COVID-19 and Sepsis
    • Free 90-day StayAlert! Trial
    • CMS Releases Telehealth and Telemedicine Tool Kit for Long-Term Care Nursing Homes
    • World TB Day – It’s Time to End TB!
    • Identifying Human Trafficking Victims
    • Patient Safety Awareness Week – Resources to Help Keep Patients Safe
    • Happy International Women’s Day!
    • So Many Policies and Procedures, So Little Time – Why Healthcare Organizations Struggle
    • HHS Reports Increase in Medicare Patients Being Hospitalized with Sepsis
    • Random Acts of Kindness Day
    • What Can Policy Management Software Do For Your Organization?
    • HHS Health Sector Cybersecurity Coordination Center (HC3) Warns of Coronavirus Themed E-mail Phishing
    • Happy New Year!
    • A Webinar Hosted by MCN Healthcare and EBSCO
    • Join Us in Celebrating Healthcare Quality Week!
    • Talking to Your Patients about Healthcare Fraud
    • October Is Breast Cancer Awareness Month!
    • GE Sponsored Webinar
    • EBSCO Information Services and MCN Healthcare Partner to Offer Healthcare Policy Expertise
    • MCN Healthcare: Coming to Orlando, FL, and Baltimore, MD!
    • Achieve Safety and Compliance in Your Healthcare Organization
    • MCN Healthcare Team Runs/Walks for Sepsis Awareness
    • MCN Policy Manager: Enhance Operational Efficiency and Meet Compliance at Your Convenience
    • Speak Up For Patient Safety – World Patient Safety Day – September 17, 2019
    • Our Story So Far— Who Is MCN?
    • September is Sepsis Awareness Month
    • CMS IPPS Final Rule Takes Aim at Antimicrobial Resistance
    • Happy National Nurses Week
    • World Tuberculosis Day 2019
    • Patient Safety Awareness Week
    • Sepsis Survivor Week
    • Are You Drowning in a Sea of Policies and Procedures?
    • Sepsis Webinar: Infection Control & Antimicrobial Stewardship
    • HHS HIPAA Settlement Reminds Hospitals to Obtain Patient Authorization Prior to Filming
    • Top 10 Challenges/Issues/Opportunities in Healthcare for 2019
    • Sepsis Alliance – It’s About Time
    • September is Sepsis Awareness Month
    • Hospitals Against Violence Day of Awareness
    • Happy Nurses Week!
    • The Nurse that I am Today
    • What Nursing Means to Me
    • Why Compliance and Risk Leaders Choose MCN Healthcare
    • How to Compare Tools for Healthcare Compliance and Regulation
    • Patient Safety Awareness Week
    • So Many Documents, So Little Time – Why Compliance Leaders Struggle
    • New CDC Training on Antibiotic Stewardship
    • Resource Guide for Measuring Compliance Program Effectiveness
    • Top 5 Challenges In Healthcare Compliance and Risk
    • One Health Day
    • To Wage War On Superbugs, FDA Clears Way For Scope With A Disposable Piece
    • Regional Anesthesia – An Alternative to Opioids
    • Why Start Enhanced Recovery After Surgery (ERAS) Protocols
    • Sepsis Awareness Month – Faces of Sepsis II
    • Sepsis Awareness Month: Faces of Sepsis
    • Save a Life by Learning the Signs of Sepsis
    • Sepsis Alliance Gala, September 14, 2017
    • September is Sepsis Awareness Month
    • The New War on Sepsis
    • Recent OIG Settlement Underscores Need for Strong EMTALA Policies
    • Solar Eclipse Safety
    • CMS Regulations and Legionella
    • HHS Releases Improved Web Tool to Highlight Recent Breaches of Health Information
    • When Wounds Won’t Heal, Therapies Spread — To the Tune of $5 Billion
    • Fire and Smoke Door Annual Testing Requirements in Health Care Occupancies – CMS Clarification
    • Fraud and Billing Mistakes Cost Medicare — And Taxpayers — Tens Of Billions Last Year
    • AUG 1 – NEW: Outpatient Rehabilitation Policy and Procedure Manual
    • AUG 1 – Rehabilitation Services Policy and Procedure Manual (Inpatient)
    • AUG 1 – OSHA Compliance Manual
    • Scope Maker Olympus Hit with $6.6 Million Verdict in Superbug Outbreak Case
    • CDC Releases Antimicrobial Stewardship Resource for Small and Critical Access Hospitals
    • Women with High-Risk Pregnancies Far More Prone to Heart Disease
    • CDC – Opioid Prescribing is Still High and Varies Widely throughout the U.S.
    • New on the Streets: Drug for Nerve Pain Boosts High for Opioid Abusers
    • Labor and Delivery Policy and Procedure Manual
    • Postpartum Policy and Procedure Manual
    • Nursery Policy and Procedure Manual
    • ‘Petya’ Cyber Attack Spreading Globally
    • HHS Issues Cyber Notice: Hidden Cobra and Microsoft Updates
    • Widow Unleashes Court Fight Against Scope Maker Olympus Over Superbug Outbreak
    • World Blood Donor Day – June 14, 2017
    • CMS Issues Proposed Revision Requirements for Long-Term Care Facilities’ Arbitration Agreements
    • Administrative Manual for Critical Access Hospitals
    • HIPAA Guidelines Policy and Procedure Manual
    • Leadership Manual
    • Report on Improving Cybersecurity in the Health Care Industry Released
    • Caring For a Loved One? Care for Yourself, Too
    • Joint Commission Clarifies Four Life Safety Code Requirements
    • Medicare Failed to Investigate Suspicious Infection Cases from 96 Hospitals
    • AHRQ Releases Toolkit to Improve Safety in Ambulatory Surgical Centers.
    • Update on International Cyber Threat to Healthcare Organizations
    • National Women’s Health Week May 14 – 20, 2017
    • Surgical Services Policy and Procedure Manual
    • Post Anesthesia Care Unit Policy and Procedure Manual
    • National Nurses Week: May 6 – 12
    • National Hospital Week May 8 – 12, The Healing Heart of Healthcare
    • MCN Healthcare Celebrates 30 Years!
    • SAVE LIVES: Clean Your Hands – Fight Antibiotic Resistance – It’s in Your Hands
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – World Malaria Day
    • Severe Shortage of Home Health Workers Robs Thousands of Proper Care
    • OIG Releases Resource Guide for Measuring Compliance Program Effectiveness
    • Another HIPAA Settlement Highlights Need for Risk Analysis of ePHI Environment
    • Medication Errors – We Know They Happen
    • Coming Full Circle, Doulas Cradle the Dying
    • The CDC Warns of Emerging Fungus in Healthcare Facilities – Candida auris
    • World Health Day – April 7, 2017
    • Dialysis Policy and Procedure Manual
    • Ambulatory Care Facility – Administrative Manual
    • Ambulatory Care Facility – Environment of Care Manual
    • By Law, Hospitals Now Must Tell Medicare Patients When Care Is ‘Observation’ Only
    • Top 10 Patient Safety Concerns for Healthcare Organizations 2017
    • Two Words Can Soothe Patients Who Have Been Harmed: We’re Sorry
    • Patient Safety Awareness Week – Policies and Procedures Matter in Patient Safety
    • Patient Safety Awareness Week – AHRQ Toolkit for LTC Facilities to Help Reduce CAUTIs
    • The Essential Role of Leadership in Developing a Safety Culture
    • 500 Cities Project – Population Health
    • Home Health Policy and Procedure Manual
    • Home Infusion Therapy Policy and Procedure Manual
    • Hospice Policy and Procedure Manual
    • HCCA’s 21st Annual Compliance Institute
    • How Long You Stay On Opioids May Depend On The Doctor You See In the E.R.
    • HCCA’S 21st Annual Compliance Institute
    • Nursing Home Antibiotic Stewardship Program
    • HCCA’s 2017 Compliance Institute
    • Joint Commission Issues Addendum to Sentinel Event, Issue 45 – Preventing Violence in the Health Care Setting
    • Life Safety and Interim Life Safety Management Manual
    • Utilities and Equipment Management Policy and Procedure Manual
    • Emergency Management and Bioterrorism Manual
    • February is American Heart Month – Changes Everyone Can Make
    • AHRQ Toolkit to Improve Safety for Mechanically Ventilated Patients
    • Antimicrobial Medications – Patient Education
    • CMS Recommendations for Providers and Suppliers for Cyber Security
    • CMS Issues Guidance on Implementing the Medicare Outpatient Observation Notice
    • Outpatient Visits for Influenza-like-Illness are Above the National Baseline: Minimize False Rapid Influenza Diagnostic Tests
    • CMS Publishes Revised Home Health Agency Conditions of Participation – Effective July 13, 2017
    • Battery-powered Mobile Medical Carts – Fire Risks
    • FDA Bans Powdered Gloves – Exam and Surgeon
    • NEW Ambulatory Infusion Center Policy and Procedure Manual
    • Anesthesia Policy and Procedure Manual
    • TJC Issues Clarification on Secure Text Messaging of Patient Care Orders
    • Long-Term Care Regulation: Enforcement of Rule Prohibiting Use of Pre-dispute Binding Arbitration Agreements is Suspended so Long as Court Ordered Injunction Remains in Effect
    • Happy Holidays from MCN Healthcare
    • CMS Releases Updated Medicare Outpatient Observation Notice (MOON)
    • New Joint Commission National Patient Safety Goal for Long Term Care Organizations
    • Decorating for the Holidays? Keep Safety in Mind
    • CMS Emergency Preparedness Requirements FAQs
    • Anesthesia Policy and Procedure Manual
    • Emergency Department Policy and Procedure Manual
    • Office of Inspector General Issues FY 2017 Work Plan
    • HAPPY THANKSGIVING
    • Thankfulness for Life: Lessons Learned as a Hospice Nurse
    • Grateful for Nurses
    • MCN Healthcare’s Policy Management Series: Policy and Procedure Development
    • Strategies for Transitioning to New Tubing Connectors
    • Anesthesia Policy and Procedure Manual
    • Pain Management Policy and Procedure Manual
    • Happy Halloween from MCN Healthcare
    • HIPAA Settlement Underscores Importance of Managing Security Risks
    • HHS’ National Action Plan to Prevent Health Care-Associated Infections – New Targets and Metrics
    • Is Your Organization Ready for Influenza Season?
    • CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler Devices Used during Cardiac Surgery
    • Central Service Policy and Procedure Manual
    • Ambulatory Surgical Center Policy and Procedure Manual
    • Surgical Services Policy and Procedure Manual
    • HHS Office for Civil Rights Issues Guidance on HIPAA and Cloud Computing
    • CDC Recommendations for Pre-Conception Counseling – Zika Virus
    • Antibiotic “Time outs”
    • MCN Employee Runs Marathons and Guides Athletes with Disabilities to the Finish Line
    • ACA Section 1557 – What Your Hospital Needs to Know
    • Last Week of Sepsis Awareness Month
    • CMS Emergency Preparedness Requirements for Hospitals – Part II
    • Advance Care Planning and Medicare
    • Sepsis Awareness Month
    • CMS Final Rule Addresses Emergency Preparedness
    • MCN Employees Cycle for a Cause on a Meaningful 9/11 Ride
    • National Suicide Prevention Week – September 5 – 11, 2016 and World Suicide Prevention Day – September 10, 2016
    • Influenza Pandemic Preparedness Guide
    • Infection Prevention and Control Manual
    • Emergency Management and Bioterrorism Manual
    • Infection Control and Toys
    • CDC Health Update – Influx of Fentanyl-laced Counterfeit Pills and Toxic Fentanyl-related Compounds
    • Changing Terminology: “Pressure Ulcer” Now to be referred to as “Pressure Injury”
    • Best Practices for Preventing Wrong Site, Wrong Procedure and Wrong Person Surgery
    • August 2016 Marks 5 Year Anniversary of National Breastfeeding Month
    • Patient Falls Top TJC’s 2Q 2016 List of Reported Sentinel Events
    • Mosquitoes – One of the Deadliest Animals in the World
    • Primary Medical Home Interdisciplinary Team
    • Home Health Policy and Procedure Manual
    • Durable and Home Medical Equipment Compliance Manual
    • Hospice Policy and Procedure Manual
    • AABB and American Red Cross Warn of Critical Blood Supply Shortage
    • CMS Releases Overall Hospital Quality Star Rating on Hospital Compare
    • The Joint Commission’s NEW Standard MM.09.01.01 – Antimicrobial Stewardship
    • Ambulatory Surgical Center Policy and Procedure Manual
    • GI Lab Policy and Procedure Manual
    • Administrative Manual for Ambulatory Care Facilities
    • How is Your Hospital Dealing with Pokémon GO?
    • HHS Announces New Actions to Combat Opioid Epidemic
    • 24th Annual Health Forum/American Hospital Association Leadership Summit, July 17 -19, 2016
    • CMS Issues Proposed Rule for Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System
    • Antimicrobial Stewardship Program
    • CMS Finalizes Rule Giving Providers and Employers Improved Access to Information for Better Patient Care
    • Accessing Investigational Drugs Outside of a Clinical Trial
    • Medicare and Medicaid Programs – Hospital and Critical Access Hospital (CAH) Changes to Promote Innovation, Flexibility, and Improvement in Patient Care – Proposed Rule
    • HIPAA Regulations and Leaving Patient Messages on Answering Machines
    • UPDATE: Hospitals will have until November to comply with new CMS Requirements addressing 2012 Life Safety Code
    • World Blood Donor Day – June 14, 2016
    • HHS Final Rule on Reducing Health Care Disparities
    • Patient and Family Communication When Unexpected Events Cause Patient Harm
    • Dr. Diane Heine – MCN Healthcare Regulatory Expert and Writer – to Speak at CIHQ’s 2016 Accreditation & Regulatory Summit
    • WHO Publishes News Release on Summer Olympics and Zika Virus
    • Evaluation of a Critical Access Hospital’s Programs
    • Administrative Manual for Critical Access Hospitals
    • Home Health Policy and Procedure Manual
    • Hospice Policy and Procedure Manual
    • Colistin-resistant mcr-1 E. coli Discovered in U.S.
    • CMS Publishes Final Rule on Fire Safety Requirements for Certain Health Care Facilities
    • NPSF Patient Safety Congress May 23-25, 2016
    • Safety of Clinical Alarm Systems
    • CDC Launches Clean Hands Count Campaign
    • Treatment Modalities and the Patient’s Treatment Plan
    • National Hospital Week, May 8 -14, 2016
    • Texting Orders
    • National Women’s Health Week May 8 – 14, 2016
    • Medical Office Policy and Procedure Manual
    • Administrative Manual for Ambulatory Care Facilities
    • Ambulatory Services Environment of Care Manual
    • National Nurses Week May 6 – 12, 2016
    • Being a Nurse
    • Joint Commission Deletes 131 Requirements for the Hospital Program
    • Homeland Security Warns Hospitals about Ransomware Risks
    • Podiatrists Completing H&Ps
    • CMS Medicare Quarterly Provider Compliance Newsletter – Billing Errors
    • National Pain Strategy Released
    • World Health Day – April 7, 2016 – Beat Diabetes
    • DME: CMS Face-to-Face Requirement
    • Surgical Services Policy and Procedure Manual
    • Anesthesia Policy and Procedure Manual
    • Post Anesthesia Care Unit Policy and Procedure Manual
    • Don’t Have the Time to Write Policies and Procedures?
    • HHS Office of Civil Rights Launches Phase 2 of HIPAA Audit Program
    • Do You Receive StayAlert! Notices in Your InBox?
    • Organ Transplant Interpretive Guidelines Update
    • Patient Safety Awareness Week March 13-19. Have You Taken the Pledge?
    • Patient Safety – What Exactly Is It?
    • Patient Safety Awareness Week March 13–19, 2016
    • Policy and Procedure Development
    • Eyewash Stations
    • Joint Commission Issues Sentinel Event Alert 56 – Detecting and Treating Suicide Ideation in All Settings
    • Comprehensive Long Term Care Policy and Procedure Manual
    • Long Term Care Environment of Care Manual
    • Home Health Policy and Procedure Manual
    • Reporting of Cases of the Zika Virus
    • Unintended Retention of a Foreign Object Once Again Tops Joint Commission List of Most Frequently Reported Sentinel Events
    • Pain Points
    • New USP Chapter: Hazardous Drugs – Handling in Healthcare Settings
    • Medical Device Reporting Requirements
    • Hospital Surveyor Worksheets
    • U.S. Senate Report Finds Fault with Hospitals Reporting Processes during Outbreak of Infections Linked to Medical Scopes
    • Medical Office Policy and Procedure Manual
    • HIPAA Guidelines Policy and Procedure Manual
    • Medical Records Health Information Management Manual
    • Advantages of MCN Healthcare’s Policy Management Software
    • Reporting Adverse Events Related to Medical Devices
    • Divergent Practices
    • HIPAA Regulations and a Patient’s Right to Access Health Information
    • CDC Issues Health Advisory about Recognizing, Managing, and Reporting Zika Virus Infections
    • Nurses Extraordinaire
    • Home Health Agency Disposal of PHI
    • HHS and USDA Release New Dietary Guidelines
    • The Third World
    • Nursing Staff Preparing CSPs
    • Schools for the Disabled and for the Blind
    • Home Health Policy and Procedure Manual
    • Ambulatory Surgical Center Policy and Procedure Manual
    • Cardiac and Pulmonary Rehabilitation Policy and Procedure Manual
    • Season’s Greetings from MCN Healthcare
    • Stark Law
    • Guide to Providing Effective Communication and Language Assistance Services
    • Critical Access Hospitals – CMS Definitions of Spouse and Marriage
    • Surgery and Pharmacy
    • Focused Dementia Care Survey Tools
    • FDA Issues Safety Communication for Intravascular Medical Devices
    • Comprehensive Compliance Plans for Healthcare Organizations
    • Administrative Manual for Critical Access Hospitals
    • Wound Management Policy and Procedure Manual
    • CMS Revising Discharge Planning Requirements
    • The Toby
    • Antibiotic Resistance
    • The People
    • CIHQ Requirements for Graduate Medical Education Programs
    • Joint Commission Warns that Temporary Names Put Newborns at Risk
    • Updated CMS Interpretive Guidelines for Pharmaceutical Services
    • Life as a Mission Team Member
    • Home Health Policy and Procedure Manual
    • Imaging Services Policy and Procedure Manual
    • Long Term Care Policy and Procedure Manual
    • ASC Infection Control Surveyor Worksheet
    • Increase in Fentanyl Drug Confiscations and Fentanyl-related Overdose Fatalities
    • Antibiotic Stewardship Program
    • CDC – Urgent Need for Improved Controlled Substance Prescribing Practices
    • Opening the Mind
    • Administrative Manual for Critical Access Hospitals
    • Home Health Policy and Procedure Manual
    • Ambulatory Surgical Services Policy and Procedure Manual
    • Administrative Manual for Ambulatory Care Facilities, version 10.0.2
    • Neonatal Intensive Care Unit Policy and Procedure Manual, version 3.0.2
    • Social Service and Discharge Planning Policy and Procedure Manual, version 4.0.2
    • LindenGrove Case Study
    • Poplar Bluff Regional Medical Center
    • Presbyterian/St. Luke’s Medical Center
  • Category: MCN Foundation
    • Adventures in Music and Culture with Peyton Shuffield: Enyan Denkyira, Ghana
    • We did it! MCN Foundation, FICCI-FLO and YOU!
    • Global Hand Washing Day October 15, 2018
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World – World Breastfeeding Week
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World – Elder Abuse On the Rise
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – Human Trafficking – A Form of Modern Slavery
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – Tuberculosis
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – Hepatitis
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – World Cancer Day
    • GivingTuesday All YEAR! Help to Empower Women and Improve Health Around the World!
    • #GivingTuesday Is Here!
    • National Health Education Week
    • World Hepatitis Day – July 28, 2016
    • World Malaria Day – April 25, 2016
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 7
    • MCN Foundation’s Campaign – We are grateful.
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 6
    • MCN Foundation Fundraiser – For the love of a girl
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 5
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 4
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 3
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 2
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya
    • MCN Foundation Works to Create Healthier Communities Around the World
  • Category: Policy Management
  • Category: Press Releases
    • MCN Healthcare Rebrands as MCN Solutions
    • Jessica Edwards Named Director of Customer Experience at MCN Healthcare
    • MCN Unveils StayAlert! Plus
    • Valeur Named To National Dance Company’s Board of Directors
    • MCN Healthcare Celebrates 30th Anniversary
    • MCN Healthcare Announces Expansion
    • MCN Healthcare Announces New Head of Sales and Marketing Efforts
  • Category: Uncategorized
    • Temporary Regulatory Changes from CMS – Verbal Orders
    • CMS Regulatory Changes in Response to COVID-19 Outbreak
    • FDA Updates
    • Joint Commission Urges Hospitals to Prepare for COVID-19 Surge
    • Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV)
    • Healthy People 2020
    • Raising Awareness for World Cancer Day
    • Go Red for Women: Ending Heart Disease and Stroke in Women
    • Advantages of Using EBSCO’s Dynamic Health with Policy Manager
    • Raising Awareness for National Blood Donor Month
    • The Benefits of Policy Manager
    • World Antibiotic Awareness Week 2019
    • The Benefits of Technology in Healthcare
    • We’re Celebrating Corporate Compliance and Ethics Week!
    • Cybersecurity and Your Healthcare Organization
    • Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling
    • OIG April 2019 Work Plan Updates – Home Health and ESRD
    • New Joint Commission New Quick Safety Issue Addresses Drug Diversion and Impaired Health Care Workers
    • CMS Updates Surveyor Guidance on Immediate Jeopardy
    • Class I Recall of CoaguChek XS PT Test Strips
    • Stryker Launches Voluntary Field Action for Specific Units of the LIFEPAK 15 Monitor/Defibrillator
    • CDC Provides First In-Season Estimates of Flu Illnesses
    • Joint Commission Issues Sentinel Event Alert on Developing a Reporting Culture
    • Holiday Decoration Safety Considerations
    • Class I Recall of Zimmer Biomet, Inc. Spinal Fusion and Long Bone Stimulators
    • Fresenius Kabi Recall of Sodium Chloride Injection, USP, 0.9%
    • CDC and APIC Announce Quick Observation Tools to Help Prevent Healthcare-associated Infections
    • FDA Safety Communication – Cybersecurity Updates Affecting Medtronic Implantable Cardiac Device Programmers
    • FDA Approves New Safety Measures for Immediate-release Opioid Analgesic Medications
    • CMS Proposes Elimination and Revision of Several Conditions of Participation
    • CMS Releases Final Interpretive Guidance for Home Health Agencies
    • Pfizer, Inc. Voluntary Nationwide Recall of One Lot of Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle
    • Joint Commission Guidance on Use of Medical Scribes / Documentation Assistants
    • Emergency Management in Long Term Care – Best Practices for the Hazard Vulnerability Analysis
    • CDC Says No Current Multi-State Measles Outbreak
    • CDC Updates Recommendations for Timing of Pregnancy after Zika Exposure
    • AAP Warns of Counterfeit Neonatal Resuscitation Textbooks
    • Class I Recall of Arkon Anesthesia Delivery System
    • Westminster Pharmaceuticals, LLC. Nationwide Recall of Levothyroxine and Liothyronine
    • CDC Raises Awareness of Emerging Public Health Risks Associated with Tianeptine
    • Joint Commission Advice for Managing Medical Device-related Pressure Injuries
    • CMS Hospice Quick Reference Guide
    • CMS Proposed Physician Fee Schedule for CY 2019
    • TJC Standards Revisions for Fluoroscopy Services
    • CDC Health Alert Network (HAN) Health Update: Rising Numbers of Deaths Involving Fentanyl and Fentanyl Analogs, Including Carfentanil, and Increased Usage and Mixing with Non-opioids
    • CMS Requirement to Reduce Legionella Risk in Healthcare Facility Water Systems to Prevent Cases and Outbreaks of Legionnaires’ Disease
    • Draeger Medical Systems, Inc. Jaundice Meter JM-103 and Jaundice Meter JM-105 Recalled Due to Misinterpretation of Display Messages for Out of Range Values
    • TJC Quick Safety Issue – Identifying Human Trafficking Victims
    • Joint Commission Changes Survey Process for Assessing Safety Culture
    • TJC Announces Change in Citations for Ligature and Self-harm Deficiencies, Effective July 1, 2018
    • Scribes in the Hospital Setting
    • EMTALA and Disasters – Key Facts about Waivers
    • Class I Recall of Terumo Recalls Sarns TCM and TCM II Cooling and Heating Systems and HX2 Temperature Management Systems
    • Joint Commission Eliminates HHA Requirement Giving Patient Written Plan of Care
    • Getting Ahead of Sepsis
    • National Drug Take Back Day – April 28, 2018
    • FDA Alerts of Risk from 24-Hour Multi-Patient Use Endoscope Connectors
    • New Joint Commission Sentinel Event Alert – Physical and Verbal Violence Against Health Care Workers
    • Avoiding Medicare and Medicaid Fraud and Abuse – Roadmap for New Physicians
    • Radiological and Nuclear Emergency Preparedness Information
    • System 83 Plus Automated Endoscope Reprocessors (AERs) by Custom Ultrasonics: FDA Safety Communication – Completed Validation Testing
    • ISMP Alert – Hydromorphine Prefilled Syringe Attracted by MRI Magnet
    • CDC Highlights New Antibiotic-Resistant Germs
    • CDC Warns of Deadly Outbreak of Yellow Fever in Brazil
    • Joint Commission New Quick Safety Issue Addresses Preventing Newborn Falls and Drops
    • International Association for Healthcare Security & Safety’s New Guideline for Threat Management
    • Class I Recall of BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD)
    • Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
    • CMS Clarification on Fine Needle Aspiration Specimen Adequacy Assessment, Rapid On-site Evaluation (ROSE) and Workload Limits
    • Joint Commission Requirements for Pain Assessment and Management
    • Health Literacy Universal Precautions – Tools for Primary Care Practices
    • FDA Warns Duodenoscope Manufacturers about Failure to Comply with Required Postmarket Surveillance Studies
    • New Medicare Card Transition Beings in Less than a Month
    • Recall of Hydromorphone HCL Injection USP by Hospira
    • Unintended Retention of Foreign Objects Tops Joint Commission 2017 Sentinel Event List
    • FDA Issues Warning about Compounded Drug Products from Cantrell Drug Company
    • Joint Commission Releases Standards Revisions Related to Project REFRESH
    • Tips to Avoid Phishing Attacks
    • TJC Revisions to Fluoroscopy Imaging Standards, Effective July 1, 2018
    • CDC Offers Antibiotic Stewardship Course
    • Consequences for HIPAA Violations Don’t Stop When a Business Closes
    • SAMHSA Guidance on Medications for Opioid Use Disorder
    • CDC Informs of Multistate Salmonella Outbreak Linked to Kratom
    • Mammography Quality Standards Act Requires Direct Communication of Results to Patients
    • Attestation for Hospitals and the National Practitioner Data Bank
    • Joint Commission Announces Three Revisions to Life Safety Chapter
    • CDC Releases 2018 Children, Adolescents and Adults Immunization Schedules
    • FDA Drug Safety Communication Updates Status for Pentax Medical Duodenoscope Model ED-3490TK
    • TJC Issues Clarification on CMS Emergency Operations Plan Exercises
    • Risk of Death and Pulmonary Embolism with Extracorporeal Photopheresis (ECP) Treatment
    • Cyber Extortion
    • CMS Revises Skilled Nursing Facility Advanced Beneficiary Notice of Non-coverage Form
    • Drug Safety Communication for Ocaliva
    • FDA Clarifies Information About Payment and Reimbursement to Research Subjects
    • Class I Recall of AirLife Humidification Chamber Heated Breathing Circuit Kits by Vyaire Medical
    • Joint Commission Recommends Strategies for Eliminating Vincristine Administration Adverse Events
    • FDA Drug Safety Communication for Loperamide
    • DEA Final Rule for Opioid Use Disorder Drugs
    • Extension of Shelf Life Provided by Baxter Healthcare Corporation to Assist with IV Solution Shortages
    • Recall of Magno-Humphries Laboratories, Inc. Basic Drugs Brand of Senna Laxative Due to Mislabeling
    • Joint Commission New Maternal Infectious Disease Requirements
    • Joint Commission Patient Safety Systems Chapter
    • FDA Safety Communication for Zoll LifeVest 4000 Wearable Cardioverter Defibrillator
    • CMS Clarifies Accrediting Organization’s Role when a Provider or Supplier’s Deemed Status has been Temporarily Removed
    • Baxter Expands Voluntary Nationwide Recall to Include Second Lot of Nexterone Injection Due to Presence of Particulate Matter
    • Joint Commission Reminds of Updated Requirements for Deemed Status Home Health Agencies
    • FDA Warning Letter Regarding Lead Testing Issues
    • International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Clopidogrel Tablets
    • CDC 2017-2018 Influenza Vaccine Recommendations
    • Centurion Labs Issues Voluntary Nationwide Recall of Certain Lots of Ninjacof and Ninjacof A
    • EMTALA Requirements and the Medical Screening Exam
    • FDA Drug Information Update on Children’s Prescription Opioid Cough Medications
    • Joint Commission Standard Deletion Related to Performance on ORYX® Measures
    • Recent OIG Settlement Underscores Need for Strong EMTALA Policies
    • Recall of Sterile Drug Products by Bella Pharmaceuticals
    • Joint Commission Quick Safety Issue 35 – Minimizing Noise and Distractions in the OR and Procedural Units
    • Class I Recall of Zenith Alpha Thoracic Endovascular Graft by Cook Medical
    • Recall of Certain Lots of Amneal Pharmaceuticals Lorazepam Oral Concentrate
    • Hospice Quality Reporting Program (HQRP) Non-Compliance
    • Fungal Disease Awareness Week
    • Surgical Gowns Highlighted in “60 Minutes” Investigation Quarantined by CDC
    • Recall – Liquid Products Manufactured by PharmaTech and Distributed by Leader Brand, Major Pharmaceuticals, and Rugby Laboratories
    • FDA Warns of Potential Risks with Liquid-filled Intragastric Balloon Systems
    • FDA Issues Alert for Sterile Drug Products from Vital Rx, dba Atlantic Pharmacy and Compounding
    • CMS Clarifies Certain Fire and Smoke Door Annual Testing Requirements in Health Care Occupancies; Extends Compliance Date
    • CDC Health Advisory Notes Increase in Reported Cases of Cyclospora cayetanensis Infection
    • Rugby Laboratories Issues Voluntary Nationwide Recall of Diocto Liquid and Diocto Syrup Manufactured By PharmaTech, LLC Due to Possible Product Contamination
    • Vulnerabilities in Certain Siemens Molecular Imaging Products
    • Class I Recall of Datascope Corp. MAQUET Intra-Aortic Balloon Pumps
    • FDA Investigates Compounded Curcumin Emulsion Product for Injection by ImprimisRx
    • OSHA Now Accepting Electronic Submissions of Injury and Illness Reports
    • Timely Reporting of Provider Enrollment Information Changes
    • CMS Updates Medicare Payment Rates, Quality Reporting Requirements
    • Joint Commission Revises Standards that Address Medication Management Maintenance, Effective January 1, 2018
    • Recall of 0.9% Sodium Chloride Injection by ICU Medical
    • CMS Issues Clarification on Provision of Services for Community Mental Health Centers
    • FDA Drug Information Update on Guardian Pharmacy’s Compounded Triamicinolone and Moxifloxacin Product for Intravitreal Injection
    • Hepatitis B Vaccine Program
    • Recall of Cyclobenzaprine HCl and Amantadine HCl by Apace Packaging
    • New Medicare Card (formerly called SSNRI)
    • HHS Releases Improved Web Tools to Highlight Breaches of Health Information
    • Cantrell Drug Company Issues Voluntary Nationwide Recall of All Sterile Drug Products Due to Lack of Sterility Assurance
    • Joint Commission Announces Survey Change for Office-Based Surgery Facilities in New York State
    • Oscor Recalls ATAR Reusable and Disposable Extension Cable(s) Due to Risk of Cable Separation from Connector
    • Class I Recall of Penumbra 3D Revascularization Device by Penumbra
    • FDA Safety Communication on Updated Status of FUJIFILM Medical Systems, U.S.A., Inc. Model ED-530XT Duodenoscopes
    • CMS Issues Proposed 2018 Physician Fee Schedule
    • HHS Issues Emergency Preparedness Resources for August Solar Eclipse
    • OIG Work Plan – July 2017 Updates
    • CMS Issues Revised Civil Money Penalty (CMP) Policies and CMP Analytic Tool
    • CMS Proposes 2018 Policy and Rate Changes for Hospital Outpatient, Ambulatory Surgical Center Payment Systems
    • CMS Memorandum Clarifies of Hepatitis C (HCV) Screening Exception for End Stage Renal Disease
    • Joint Commission’s New and Revised Pain Assessment and Management Requirements – Performance Improvement
    • CDC Offers New Vaccine Administration e-Learn Modules
    • CDC Health Advisory – Patients Receiving Eculizumab (Soliris®) at High Risk for Invasive Meningococcal Disease despite Vaccination
    • CMS Delays Effective Date for Home Health Conditions of Participation
    • Joint Commission Issues New and Revised Pain Assessment Requirements, Effective January 1, 2018
    • Recall of Atar Extension Cables by Oscor
    • Recall of Novopen Echo Insulin Delivery Device by Novo Nordisk
    • CMS Issues New Guidance for the Formatting of the Plans of Correction
    • Joint Commission Proposes New requirements for Maternal Status Documentation
    • CMS Issues Updated Hospital Discharge Appeal Notices
    • Time to Review Hurricane Readiness Policies
    • CDC Releases Influenza Vaccine Composition for 2017-2018
    • Petya Cyber Attack
    • PharMEDium Services Issues Voluntary Nationwide Recall of Specific Lots of Potassium Phosphate and Succinylcholine Chloride
    • The Joint Commission Proposes New Requirement Related to Measuring Pediatric Weights in Kilograms
    • Recall: Succinylcholine Chloride 20mg/mL 5mL Syringe by Fagron Sterile Services
    • Joint Commission Requirements for Providers Serving as Interpreters for Fellow Providers
    • Joint Commission Offers New Compendium of Resources for Venous Thromboembolism
    • Recall: Potassium Phosphate and Succinylcholine by Advanced Pharma
    • HHS Issues Cyber Notice
    • Recall: Venture Catheters by Vascular Solutions
    • Five Ways for Providers to Prepare for the New Medicare Cards
    • FDA Announces Availability of Draft Guidance on Electronic Records and Electronic Signatures in Clinical Investigations
    • CMS Requirements to Reduce Legionella Risk in Healthcare Facility Water Systems
    • Datascope System CS100, CS100i and CS300 Intra-Aortic Balloon Pumps Field Correction – Potential Electrical Test Failure Code
    • Teva Pharmaceuticals, USA Extends Voluntary Nationwide Recall to Consumer/User Level for One Lot of Paliperidone Extended-Release Tablets
    • Recall of Clindamycin Injection USP ADD-Vantage Vials by Alvogen
    • Recall of Sodium Bicarbonate Injection 8.4 Percent USP, Neut (Sodium Bicarbonate 4 Percent Additive Solution), Quelicin (Succinylcholine Chloride Injection USP), and Potassium Phosphates Injection by Hospira
    • Recall of Unexpired Nitroglycerin Injection in 5 Percent Dextrose USP by Advanced Pharma in Houston
    • FDA Safety Communication for Frameless Stereotaxic Navigation Systems
    • FDA Seeks Comment on Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids
    • National Time Out Day
    • Phillips Company Issues Voluntary Worldwide Recall of All Topical Products Due to Concerns of Manufacturing Practices
    • Recall of One Lot of Eliquis (apixaban) 5 mg Tablets
    • Recent Study Advises of Potential Neonatal Ethanol Exposure from Ethanol-based Hand Sanitizers in Isolettes
    • Quick Response Cyber Attack Checklist and Graphic
    • Data Submission Open for AHRQ Surveys on Patient Safety Culture Hospital Survey
    • FDA Releases List of Reusable Medical Devices Requiring Validated Instructions
    • Joint Commission adds New Requirement for Ambulatory Care Organizations Providing Sleep Center Services
    • Change in Institutional Review Board Oversight
    • Magellan Diagnostics Inc. Expands Recall for LeadCare Testing Systems Due to Inaccurate Test Results
    • CMS Issues Proposed Revision Requirements for Long-Term Care Facilities’ Arbitration Agreements
    • CMS Announces New Medicare Cards
    • TJC Clarification about Rated Fire Door Assembly Installed in Lesser Rated or Non-rated Barrier
    • Joint Commission Updates Sentinel Event Alert, Issue 47 – Radiation Risks of Diagnostic Imaging
    • TJC Clarifications about Emergency Department (ED) Occupancy Classification
    • Class I Recall of SpF PLUS-Mini and SpF XL IIB Implantable Spinal Fusion Stimulators by Zimmer Biomet
    • Recall of One Lot Number of Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles
    • Recall of Mibela 24 Fe Chewable Tablets by Lupin Pharmaceuticals Inc.
    • Class I Recall of Magellan Diagnostics Inc. LeadCare Plus and Ultra Testing Systems
    • Joint Commission Clarifies Requirements for Fire Drills
    • TJC Issues Clarifications to Life Safety Code Requirements
    • Class I Recall of Abbott-Thoratec HeartMate II LVAS Pocket System Controller
    • Joint Commission Revises National Patient Safety Goals Related to Healthcare-Associated Infections
    • FDA Safety Communication about Gadolinium-based Contrast Agents
    • Class I Recall of V60 Non-invasive Ventilator by Respironics
    • CMS Requirements for Notice of Transfer or Discharge in Long Term Care
    • CDC Issues Health Advisory about Potential for Falsely Low Blood Lead Test Results from LeadCare® Analyzers
    • HHS Updates on International Cyber Threat to Healthcare Organizations
    • FDA Safety Communication – Magellan Diagnostics’ LeadCare Testing Systems Use with Venous Blood
    • Joint Commission Deletes Numerous EPs from Nonhospital Accreditation Programs
    • Class I Recall of ReFlow’s Wingman 35 Crossing Catheters due to Tip Separation
    • Recall of Coronary Catheters by Abbott – Difficulty in Removing Balloon Sheath
    • FDA Drug Safety Communication for Canagliflozin (Invokana, Invokamet)
    • Update on International Cyber Threat to Healthcare Organizations
    • CDC Updates Surgical Site Infection Guidelines
    • New Joint Commission Field Reviews
    • Joint Commission Highlights Importance of Crash Cart Preparedness
    • FDA Drug Safety Communication – Updated Warnings for Oral and Injectable Fluoroquinolone Antibiotics
    • CMS Releases Lookup Tool to Help Clinicians Determine MIPS Participation Status
    • Spotlight on Emergency Preparedness the Long Term Care Environment
    • Class I Recall of Ventricular Assist Device Controllers and DC Adapter by Medtronic Mechanical Circulatory Support (formerly HeartWare Inc.)
    • Recall of Wingman35 Crossing Catheters by ReFlow Medical – Tip Splitting or Separation
    • Medtronic Letter to Healthcare Providers Regarding NavLock Tracker
    • World Hand Hygiene Day, May 5, 2017
    • Class I Recall of Medtronic HVAD(TM) System Controllers and DC Adapters
    • Best Practices for Use of Fingerstick Devices
    • FDA Drug Safety Communication about General Anesthetic and Sedation Drugs for Children
    • Joint Commission Announces Completion of Phase III EP Review Project
    • CMS Releases Electronic Staffing Submission – Payroll-Based Journal Update
    • FDA Warns of Fraudulent Cancer Treatments
    • Advancement of Medical Instrumentation (AAMI) Report – Risk Management of Radio-frequency Wireless Coexistence for Medical Devices and Systems
    • Recall of Hospira 25% Dextrose Injection, USP (Infant)
    • CDC Releases General Best Practice Guidelines for Immunization
    • FDA Issues Drug Safety Communication – Restricting Use of Codeine and Tramadol Medicines in Children, Recommending Against Use in Breastfeeding Women
    • CMS Proposes Regulation Changes for Accrediting Organizations (AOs) Transparency and Termination Notices
    • Joint Commission Proposes Requirements for the New Thrombectomy-capable Stroke Center Certification Program
    • CDC Interim Guidance for Managing Occupational Exposure to Zika Virus for Healthcare Personnel
    • OIG Releases Resource Guide for Measuring Compliance Program Effectiveness
    • Joint Commission Clarifies Requirements for Monitoring and Maintenance of Refrigerators in Patient Rooms
    • CMS Releases Administrative Simplification Factsheet
    • DNV GL Advisory Notice – NIAHO Accreditation Requirements, Interpretive Guidelines and Surveyor Guidance for Critical Access Hospitals
    • Recall of StrataMR Adjustable Valves and Shunts by Medtronic
    • Recall of Sterile Compounded Products by Isomeric Pharmacy Solutions
    • TJC Requirements for Updating H&P during Inpatient Stay
    • Medtronic Announces Worldwide Voluntary Field Corrective Action for Newport™ HT70 and Newport™ HT70 Plus Ventilators
    • Medication Titration Orders
    • CMS Releases Information to Assist Providers and Suppliers in Meeting the New Training and Testing Requirements of the Emergency Preparedness Requirements
    • FDA Announces Recall of EpiPen and and EpiPen Jr Auto-Injector
    • CMS Conditions of Participation for Home Health Agencies – Proposed Delay of Effective Date
    • Class I Recall of the Prelude Short Sheath Introducer by Merit Medical Systems
    • CMS Home Health Conditions of Participation – Comprehensive Assessment
    • FDA Updates Heater-Cooler Device Information
    • CMS Home Health Conditions of Participation Related to the Provision of Written Information to the Patient
    • CDC Updates Specimen Collection, Shipping, and Testing Guidance for Suspected Acute Flaccid Myelitis (AFM) Cases
    • Class I Recall of Phillips Healthcare’s HeartStart MRx Monitor Defibrillator
    • CMS Home Health Conditions of Participation Related to Coordination of Care
    • CMS Home Health Conditions of Participation – Care Planning
    • Joint Commission Proposes Revisions to National Patient Safety Goal Requirements Related to Suicide
    • FDA Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
    • CDC Warns of Potential Increased Risk to Blood and Tissue Safety for Certain FL Counties
    • FDA Investigating Increased Rate of Major Adverse Cardiac Events with Absorb GT1 Bioresorbable Vascular Scaffold (BVS) by Abbott Vascular
    • New Tools for Patient-Based Safety Interventions in Primary Care
    • FDA Drug Safety Communication for Viberzi (eluxadoline)
    • Policies that Address Delays in Treatment
    • Best Practices to Prevent Patient Falls in Hospitals
    • Class I Recall of SynchroMed II and SynchroMed EL Implantable Drug Infusion Pumps by Medtronic
    • CMS Releases FAQs for Medicare Outpatient Observation Notice (MOON)
    • FDA Safety Communication for SPS-1 Static Preservation Solution Distributed by Organ Recovery Systems
    • CMS Home Health Conditions of Participation – Patient Rights (Effective July 13, 2017)
    • FDA Safety Communication – Balloon Angioplasty Devices to Treat Autonomic Dysfunction
    • Revisions to Joint Commission’s Life Safety Chapter, Effective July 1, 2017
    • CDC Study Estimates 20-fold Increase in Birth Defects Related to Zika
    • HHS OIG Issues Fraud Alert – Telephone Number Used in Scam
    • New CMS MLN Matters Article Addressing Advance Care Planning Implementation for OPPS
    • Joint Commission Issues Sentinel Event Alert 57 – The Essential Role of Leadership in Developing a Safety Culture
    • TJC Requirements for Testing and Maintaining Non-high-risk Utility Systems
    • Avella Specialty Pharmacy Announces Recall of Injectable Products
    • Radiological Health Reporting Forms
    • TJC Revisions to Program Requirements Based on NFPA 2012 Life Safety Code Effective July 1, 2017
    • Multi-state Outbreak of Seoul Virus – Update
    • 2016-2017 Flu Vaccine Reducing Risk by Nearly Half
    • Using Antibiogram’s in Nursing Homes
    • Class I Recall of Comprehensive Reverse Shoulder by Zimmer Biomet
    • Educating Nursing Home Staff about Antibiotic Stewardship
    • Synergy Rx Pharmacy Recalling Human Chorionic Gonadotropin
    • CDC Releases 2017 Immunization Schedules
    • USP to Seek Second Round of Public Comments for General Chapter 797 Pharmaceutical Compounding—Sterile Preparations
    • Class I Recall of Physio-Control Recalls LIFEPAK15 Monitor and Defibrillator
    • Joint Commission Issues Addendum to Sentinel Event, Issue 45 – Preventing Violence in the Health Care Setting
    • FDA Alert – Potential Risks with Fluid-filled Intragastric Balloons
    • Recall of Ibuprofen Lysine Injection by Exela Pharma Sciences
    • Class I Recall of CareFusion’s Alaris Syringe Pump
    • New Communication Tool for Radiation Emergencies
    • OSHA Reminds Employers to Post Injury and Illness Summaries Now through April
    • FDA MedWatch – Chlorhexidine Gluconate: Rare but Serious Allergic Reactions Reported
    • Joint Commission Clarifies “Observers” Standard
    • DMEPOS Competitive Bidding Round 2019 Announced
    • Class I Recall of Halo One Thin-Walled Guiding Sheath by Bard Peripheral Vascular Inc.
    • Class I Recall of bioMerieux NucliSENS easyMAG Magnetic Silica and NucliSENS Magnetic Extraction Reagents
    • CDC Health Advisory – Investigation of Seoul Virus Outbreak Associated with Home-based, Rat-breeding Facilities in Wisconsin and Illinois
    • AHRQ Toolkit to Improve Safety for Mechanically Ventilated Patients
    • CMS Releases Instructions for Using MOON
    • Hospira Issues Recall of One Lot of Vancomycin Hydrochloride for Injection, USP
    • TJC Recommendations for Protecting Patients during Utility System Outages
    • Joint Commission Proposed Requirements Related to Pain Assessment and Management
    • REMINDER – FDA Ban on Powdered Medical Gloves is Now Effective
    • Educating Patients on Antimicrobial Medications
    • Revisions to the Federal Policy for the Protection of Human Subjects (the Common Rule)
    • FDA Safety Communication Update – ED-3490TK Video Duodenoscope by Pentax
    • FDA Safety Communication for Zoll LifeVest 4000 Wearable Cardioverter Defibrillator
    • Outpatient Visits for Influenza-like-Illness are above the National Baseline: Minimize False Rapid Influenza Diagnostic Tests
    • Voluntary Field Action for LIFEPAK 1000 Defibrillators by Physio-Control
    • Fujifilm Plans on Removing Legacy 250/450 Duodenoscope Models from Clinical Use
    • CMS Finalizes Revised Home Health Conditions of Participation
    • Recall of Medrad Intego PET Infusion System Source Administration Sets by Bayer
    • FDA Safety Concerns with Implantable Infusion Pumps in the Magnetic Resonance Environment
    • FDA Warns of Potential Problems with Battery-Powered Mobile Medical Carts
    • Joint Commission Revisions to Behavioral Health Care Standards, Effective January 1, 2018
    • Cybersecurity Vulnerabilities Identified in St. Jude Medical’s Implantable Cardiac Devices and Merlin@home Transmitter
    • Class I Recall of Nurse Assist Inc. Normal Saline Flush IV Syringes Due to Possible Burkholderia Cepacia Bloodstream Infections
    • CMS Rescinds Policy Disallowing Hospital Security Units
    • Joint Commission National Patient Safety Goal Focuses on CAUTI Prevention
    • CMS Issues Clarification of Automatic Fire Sprinkler System Installation Requirements in Attic Spaces in Long-Term Care Facilities
    • TJC Issues Clarification on Text Messaging of Patient Care Orders
    • FDA Issues Safety Communication for ZIKV Detect IgM Capture ELISA by InBios International, Inc.
    • CDC Resources for Clinicians Using New Opioid Prescribing Guidelines
    • Class I Recall of Standard Offset Cup Impactor with POM-C Handle by Greatbatch Medical
    • Clozapine REMS Delayed
    • FDA Bans Powdered Gloves (Surgeon Gloves and Exam Gloves)
    • Long-Term Care Regulation – Enforcement of Rule Prohibiting Use of Pre-dispute Binding Arbitration Agreements is Suspended
    • CDC Designates the City of Brownsville, Texas as a Zika Cautionary (yellow) Area for Testing and Travel Guidance
    • FDA Issues New Warnings for Use of General Anesthetic and Sedation Drugs in Young Children and Pregnant Women
    • Joint Commission Releases Prepublication Standards for Phase 1 Revisions to Behavioral Health Care Manual
    • Pioglitazone-containing Medicines – Updated FDA Review
    • CMS Releases Updated Medicare Outpatient Observation Notice
    • Class I Recall of Convenience Kits Containing Multi-Med Single Lumen Catheters by Centurion
    • National Influenza Vaccination Week: What Does Medicare Cover?
    • CDC Announces Updated VIS for Gardasil-9 is Available
    • Decorating for the Holidays? Keep Safety in Mind
    • CMS Posts FAQs about New Emergency Preparedness Rule
    • Class I Recall of Medtronic Recalls Neurovascular Products
    • OCR Issues Alert about Phishing Email Targeting HIPAA Covered Entities
    • It’s Time to Review Your Compliance Plan!
    • Happy Thanksgiving!
    • Class I Recall of FindrWIRZ Guidewire System by SentreHeart
    • Tri-Coast Pharmacy Inc. Voluntarily Recalling All Sterile Products Prepared Between May 17, 2016 and November 17, 2016
    • Office of Inspector General Releases FY 2017 Work Plan for Home Health
    • Recall of Sterile Drug Products by Cantrell Drug Company
    • Office of Inspector General Releases FY 2017 Work Plan for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies
    • Office of Inspector General Releases FY 2017 Work Plan for Nursing Homes and Hospice
    • Joint Commission Releases 2017 National Patient Safety Goals
    • Department of Homeland Security Issues Updated Terrorism Advisory System Bulletin
    • FDA Announces Label Changes for Essure Permanent Birth Control System by Bayer Healthcare
    • Office of Inspector General Releases FY 2017 Work Plan for Hospitals
    • Office of Inspector General FY 2017 Work Plan
    • FDA Draft Guidance on Certain Ultrasonic Surgical Aspirator Devices
    • New Guide Helps Nursing Homes Tackle Antimicrobial Stewardship
    • Transplant Centers: CMS Requirements – Clinical Experience
    • The Accreditation Council for Graduate Medical Education Seeks Input on Proposed Revisions to Common Program Requirements
    • CDC – First Cases of Candida auris Reported in the United States
    • CMS Issues Final Rule for 2017 Physician Payment Schedule
    • CMS Proposed Rule – Fire Protection Guidelines for Applicable Dialysis Facilities
    • CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler Devices Used during Cardiac Surgery
    • Strategies for Transitioning to New Tubing Connectors
    • HHS’ National Action Plan to Prevent Health Care-Associated Infections – New Targets and Metrics
    • Social Security Number Removal Initiative (SSNRI)
    • CMS Extends Timeline for Hospice “Extraordinary Circumstances” Exemption
    • FDA Announces Class-wide Labeling Changes for All Prescription Testosterone Products
    • Class I Recall of St. Jude Medical Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy Defibrillators (CRT-D)
    • Class I Recall of HeartWare Ventricular Assist Device Pumps by HeartWare Inc.
    • New FDA Website for Reporting Allegations of Regulatory Misconduct
    • New National Health Care-Associated Reduction Targets and Metrics
    • Class I Recall of Willy Rusch Tracheostomy Tube Set by TeleFlex Medical
    • Radiation Therapy Devices by Multidata Systems International: Discontinue Use – Concerns about Risks to Patients
    • CDC Health Advisory Updates Guidance – Zika Virus and Miami-Dade County, Florida
    • New HIPAA Settlement Underscores Importance of Managing Security Risks
    • Medtronic Announces Voluntary Recall of its Pipeline Embolization Device, Alligator Retrieval Device, X-Celerator Hydrophilic Guidewire, Ultraflow and Marathon Flow Directed Micro Catheters
    • ACHC Requirements for Informing Patients of the Grievance Process
    • Class I Recall of Skintact DF29N Multi-function Defibrillation Electrodes by Leonhard Lang
    • FDA Updated Safety Communication – Stӧckert 3T Heater-Cooler System by LivaNova PLC (formerly Sorin Group Deutschland GmbH)
    • CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler Devices Used during Cardiac Surgery
    • Medicare Quarterly Provider Compliance Newsletter
    • New HHS Rule Provides Public with More Information about Clinical Trials
    • FDA Safety Communication – Premature Battery Depletion of St. Jude Medical ICD and CRT-D Devices
    • FDA Issues Final Rule Amending List of Drug Products That May Not Be Compounded
    • HHS Office for Civil Rights Issues Guidance on HIPPA and Cloud Computing
    • Joint Commission Changes Two Laboratory Standards
    • CMS Issues Final Rule Reforming Requirements for Long-Term Care Facilities
    • Nurse Assist Initiates Nationwide Voluntary Recall of All Unexpired Lots of I.V. Flush Syringes
    • Class I Recall of Vascular Solutions, Inc. Twin-Pass® Dual Access Catheters
    • Joint Commission Seeks Comments on Proposed revisions to National Patient Safety Goals on Health Care-Associated Infections
    • HHS Office for Civil Rights Offers Insight into Availability of PHI Maintained by a Business Associate
    • Voluntary Recall of all Unexpired Lots of Baxter International’s 50mm 0.2 Micron Filters
    • CDC Updates Interim Guidance for Pre-Conception Counseling and Prevention of Sexual Transmission of Zika
    • Institute for Safe Medication Practices Issues Alert about Possible Fluid Leakage with Parenteral Syringes
    • Antibiotic “Time outs”
    • Class I Recall of Small Battery Drive and Small Battery Drive II Adaptor and Light Adaptor by DePuy Synthes – Possible Explosion Risk
    • Joint Commission Deletes 51 Elements of Performance in Hospital Accreditation Standards
    • Affordable Care Act of 2010 – Section 1557 – Grievance Procedure Requirements for Discrimination
    • DEA Issues Warning About Carfentanil
    • HHS Issues Final Rule on ClinicalTrials.gov Requirements
    • Recall of Sterile Products by Wells Pharmacy Network – Concern for Lack of Sterility Assurance
    • HHS Releases Additional Affordable Care Act Section 1557 Resources
    • Affordable Care Act of 2010 – Section 1557 – Notices of Nondiscrimination
    • CMS Emergency Preparedness Requirements for Hospitals – Part II
    • CDC Updates Guidance for Wynwood (FL) Neighborhood with Active Zika Transmission
    • Updated Requirements for Notifying The Joint Commission about Organizational Changes
    • Recall of Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals
    • CMS Emergency Preparedness Requirements for Hospitals – Part I
    • CMS Final Rule Addresses Emergency Preparedness
    • CMS Interpretive Guidance about Protecting Resident Privacy and Prohibiting Mental Abuse Related to Photographs, Audio and or Video Recordings by Nursing Home Staff
    • Recall of Six Batches of Novo Nordisk Inc., GlucaGen HypoKit (glucagon [rDNA origin] for injection)
    • CMS Releases Additional Resources to Assist with Advance Care Planning
    • Recall of Family Eye Care Wash by united Exchange Corp.
    • Best Practices for Reducing Risk of Infections Associated with Medical Equipment, Devices and Supplies
    • Class I Recall of Cook Medical Recalls Roadrunner UniGlide Hydrophilic Wire Guide Because of Potential Coating Contamination
    • CDC Provides Example Labels for 2016-2017 Influenza Vaccine
    • FDA Drug Safety Communication: Opioid Pain or Cough Medicines Combined With Benzodiazepines – Serious Risks and Death
    • Impax Laboratories, Inc. Issues Voluntary Nationwide Recall for One Lot of Lamotrigine Orally Disintegrating Tablet 200 mg
    • CDC Health Alert – Influx of Fentanyl-laced Counterfeit Pills and Toxic Fentanyl-related Compounds Further Increases Risk of Fentanyl-related Overdose and Fatalities
    • FDA Advises Testing for Zika Virus in all Donated Blood and Blood Components in the US
    • Class I Recall of Alere’s INRatio and INRatio2 PT INR Monitoring System Due to Incorrect Test Results
    • FDA Safety Communication: Programmable Syringe Pumps – Problems with Fluid Flow Continuity at Low Infusion Rates
    • Are You Required to Comply with Electronic Standards?
    • Safety Information about Heater-Cooler Devices used During Cardiothoracic Surgery
    • CDC Health Alert Network Health Advisory Expands Guidance for Zika Virus – Miami-Dade, Florida
    • Recall of Eyesaline Eyewash by Honeywell
    • CMS Finalizes Hospital Inpatient Prospective Payment System (IPPS) and Long Term Acute Care Hospital (LTCH) Final Rule Policy and Payment Changes for Fiscal Year (FY) 2017
    • FDA Safety Communication – System 83 Plus Automated Endoscope Reprocessors by Custom Ultrasonics
    • Recall of Roadrunner UniGlide Hydrophilic Wire Guides by Cook Medical
    • FDA Issues Import Alert for All Drugs Produced by Laxachem Organics in India
    • Class I Recall of BioMerieux NucliSENS® easyMAG® Magnetic Silica (MagSil)
    • Best Practices for Preventing Wrong Site, Wrong Procedure and Wrong Person Surgery
    • HHS, HUD and DOJ Issue Letter to State and Local Agencies Regarding Life and Safety Benefits for Immigrants
    • Patient Falls Top TJC’s 2Q 2016 List of Reported Sentinel Events
    • Best Practices for Preventing Unintended Retention of a Foreign Object
    • PharmaTech Issues Voluntary Nationwide Recall of Liquid Drug and Dietary Supplements – Risk of Product Contamination
    • Joint Commission releases Sentinel Event Statistics through 2Q 2016
    • CDC Releases Updated Vaccine Information Statements
    • Recall of 0.25 Percent Bupivacaine Hydrochloride Injection, USP by Hospira
    • Class I Recall of VentStar Oxylog 3000 Pediatric Patient Breathing Circuit by Dräger
    • FDA Issues Draft Guidance – Insanitary Conditions at Compounding Facilities
    • Recall of Amikacin Sulfate Injection USP
    • Recall of Comfort Shield Barrier Cream Cloths by Sage Products – Product Contamination
    • CDC Issues Health Advisory with Travel Guidance Related to Miami Neighborhood with Active Zika Spread
    • CDC Updates Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure
    • AABB and American Red Cross Warn of Critical Blood Supply Shortage
    • FDA Issues Advice to Blood Collection Establishments on Non-Travel Related Cases of Zika Virus in Florida
    • Class I Recall of AVEA Ventilator by CareFusion – Electrical Issue May Cause Unexpected Shutdown
    • FDA Releases Influenza Virus Vaccine for the 2016-2017 Season
    • U.S. Department of Health and Human Services Office for Civil Rights (OCR) Settles HIPAA Violations with University of Mississippi Medical Center
    • Talon Compounding Pharmacy Issues Voluntary Nationwide Recall of HCG and Sermorelin Due to Lack of Sterility Assurance
    • FDA Drug Safety Communication about Fluoroquinolone Antibacterial Drugs for Systemic Use – Warnings Updated Due to Disabling Side Effects
    • Joint Commission’s NEW Standard MM.09.01.01 – Antimicrobial Stewardship
    • Schools to Hold Programming Courses In 2016
    • The Future Of Online And Mobile Banking
    • New Limited Edition Line Of Quality Headphones
    • Changing The Way We Look At Telecomunication
    • New Workout App Promises Great Results
    • News From The 2016 Technology Expo
    • Top 25 Productivity Apps Of 2016
    • Twitter Making Major Changes To Its UI
    • New Music Streaming App Release In May
    • Machine Vision’s Achilles’ Heel Revealed by Google Brain Researchers
    • The AI That Cut Google’s Energy Bill Could Soon Help You
    • Nvidia’s Eye-Tracking Tech Could Revolutionize Virtual Reality
    • Class I Recall: Angiodynamics Soft Vu Omni Flush Angiographic Catheter by Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions)
    • CDC Assisting Utah Investigation of Zika Virus Infection Apparently not Linked to Travel
    • HHS Announces New Actions to Combat Opioid Epidemic
    • Recall of Oral Liquid Docusate Sodium by PharmaTech: Contamination with B. Cepacia
    • CMS Proposes FY2017 Physician Fee Schedule
    • OCR Releases Fact Sheet on Ransomware and HIPAA
    • Recall of INRatio and INRatio2 PT/INR Monitor System by Alere: Potentially Inaccurate INR Results
    • FDA Approves a Dedicated Syringe to be used with Humulin R U-500 Insulin
    • Update: Multistate Outbreak of Burkholderia cepacia Infections
    • CMS Issues Proposed Rule for Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System
    • ACHC Requirements for Transferring a Patient Receiving Home Health Services
    • CMS Finalizes Rule Giving Providers and Employers Improved Access to Information for Better Patient Care
    • CMS Makes Correction to New Fire Safety Rule
    • Joint Commission Publishes Prepublication Requirements for New Antimicrobial Stewardship Standard MM.09.01.01
    • CDC Issues Clinical Alert to U.S. Healthcare Facilities – Candida auris
    • Joint Commission Quick Safety Issue 24 – Bullying Has No Place in Healthcare
    • Hurricane Readiness for Healthcare Providers
    • CMS Memorandum – CMS will begin Surveying for Compliance with the 2012 LSC and HCFC on November 1, 2016.
    • CDC Issues Health Update with Recommendations for Subsequent Zika IgM Antibody Testing
    • CDC Issues Health Advisory about Best Practices for Using PCR to Diagnose Haemophilus influenzae and Neisseria meningitidis and Identify Serotype or Serogroup
    • ACHC Requirements for Home Health Aide Duties
    • HIPAA Considerations and Emergency Response during Acts of Mass Violence
    • CMS Proposed Rule Prohibits Discrimination, Reduces Hospital-Acquired Conditions, and Promotes Antibiotic Stewardship in Hospitals
    • CDC Issues Health Alert about First mcr-1 Gene in E. coli Bacteria found in a Human in the United States
    • FDA Drug Safety Communication: Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR) – Strengthened Kidney Warnings
    • FDA issues Final Guidance Documents on Bulk Substances Used during Compounding
    • UPDATED Drug Safety Communication for Zecuity (sumatriptan) Migraine Patch
    • FDA Seeks Comments on Draft Guidance about Dissemination of Patient-Specific Information from Devices by Device Manufacturers
    • OCR Releases Tools to Help Individuals Understand Access to Health Information Rights under HIPAA
    • FDA Issues Drug Safety Communication for Loperamide (Imodium)
    • ACHC Requirements for Conformance with Physician Orders
    • FDA Releases Final Individual Patient Expanded Access Investigational New Drug Application Form 3926
    • FDA Issues Drug Safety Communication for Zecuity
    • ACHC Drug Regimen Review Standard – One of Most Cited Deficiencies
    • Safety Communication about the Stӧckert 3T Heater-Cooler System by Sorin Group Deustchland GmbH
    • Joint Commission Seeks Input on Proposed and New Laboratory Changes
    • Colistin-resistant mcr-1 E. coli Discovered in U.S.
    • Class I Recall of Medtronic Respiratory and Monitoring Solutions Battery Pack Used on Patient Monitors Due to Potential Fire Risk
    • CDC Issues Health Advisory Regarding Diagnostic Testing of Urine Specimens for Suspected Zika Virus Infection
    • Class I Recall of Hummi Micro-Draw Blood Transfer Device by Hummingbird Med Devices
    • CMS Survey and Certification Group 2016-2017 Nursing Home Action Plan
    • AHRQ Communication and Optimal Resolution (CANDOR) Toolkit
    • Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria Seek Input on Strategies to Combat Antibiotic-Resistance
    • CDC Monitoring Possible Zika Virus Infection among Pregnant Women in the U.S. and Territories
    • FDA Issues Drug Safety Communication for Ketoconazole Oral Tablets
    • Recall of Well Care Compounding Pharmacy Sterile Compounded Products
    • FDA Issues Drug Safety Communication for Canagliflozin (Invokana, Invokamet)
    • Nondiscrimination in Health Programs and Activities Final Rule Brings New Requirements for Accommodating Persons with Limited English Proficiency
    • FDA Seeks Comments on Draft Guidance, Use of Electronic Health Record Data in Clinical Investigations
    • HHS Issues Final Rule to Advance Health Equity and Reduce Health Care Disparities
    • FDA Issues Drug Safety Communication for Fluoroquinolone Antibacterial Drugs
    • Joint Commission Follows Suit with CMS and Adopts 2012 NFPA 101 Life Safety Code
    • CMS Clarifies Guidance on Federal Requirements for Providing Services to Justice Involved Individuals
    • FDA Issues Drug Safety Communication for Olanzapine – Rare but Serious Skin Reactions
    • New CDC Campaign Reminds Healthcare Providers that “Clean Hands Count”
    • Recall of PharMEDium Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl)
    • CMS Final Rule on Fire Safety Requirements for Certain Health Care Facilities
    • Class I Recall of Dialog+ Hemodialysis Systems by B. Braun Medical
    • Recall of Beacon Tip Technology Catheters by Cook Medical
    • Joint Commission Revises Position on Texting Orders
    • FDA Announces a Brand Name Change for Brintellix (vortioxetine)
    • May is Viral Hepatitis Month
    • CMS Proposes Replacing Meaningful Use Program
    • The CMS Updates State Operations Manual Appendix A, Pharmaceutical Services Conditions of Participation
    • FDA Drug Safety Communication on Oral Diflucan (fluconazole) During Pregnancy
    • Recall of Sensorcaine-MPF (bupivacaine HCl) by Fresenius Kabi
    • Joint Commission Deletes Requirements for Hospitals
    • Multistate Outbreak of Elizabethkingia anophelis – What You Need to Know
    • Best Practices for Compliance with Joint Commission’s Ambulatory Care Hazard Vulnerability Analysis Requirement
    • FDA Proposes Ban on Electrical Stimulation Devices Intended to Treat Self-injurious or Aggressive Behavior
    • DHS Warns Hospitals about Ransomware Risks
    • Medtronic Recalls Covidien Oridion Labeled Capnostream 20 and Capnostream 20p Patient Monitor Battery Packs
    • FDA Issues Draft Guidance Documents Related to Human Drug Compounding
    • CMS Issues Proposed Hospital Inpatient Prospective Payment System (IPPS) for Fiscal Year (FY) 2017
    • Class I Recall of the Boston Scientific Corporation Fetch 2 Aspiration Catheter
    • FDA Alerts Healthcare Professionals Not to Use Sterile Drug Products from Pharmakon Pharmaceuticals, Inc.
    • CMS Medicare Quarterly Provider Compliance Newsletter – Screening Colonoscopy and Physician Documentation
    • Recall of 50% Magnesium Sulfate Injection, USP by Hospira
    • CDC Study Confirms Zika Virus Causes Microcephaly and Other Serious Birth Defects
    • OIG Releases 2016 Compendium of Unimplemented Recommendations
    • Class I Recall of Focus Diagnostics Simplexa Herpes Simplex Virus 1 & 2 and Simplexa Group A Step Direct Kits
    • Class I Recall of G4 Platinum and G5 Mobile Continuous Glucose Monitoring System Receivers by Dexcom – Audible Alarm Failure
    • Recall of Boston Scientific‘s Fetch 2 Aspiration Catheter
    • Recall of Guardian II Hemostasis Valves by Vascular Solutions, Inc.
    • CIHQ Requirements for Interpretive and Translation Services
    • FDA Drug Information Update for Metformin-containing Medications
    • HHS Releases a National Pain Strategy
    • Joint Commission’s New Requirements for Diagnostic Imaging Services
    • CMS Memorandum: Personnel Policies for Individuals Directing or Performing Non-waived Tests
    • FDA Safety Communication: Diabetes Medications Containing Saxagliptin and Alogliptin – Risk of Heart Failure
    • Interference between Computed Tomography (CT) and Electronic Medical Devices – Current Understanding of Potential Risk
    • FDA Warns of Potential for Counterfeit Raw Material with Urogynecologic Surgical Mesh Implants by Boston Scientific
    • FDA Warns of a Lack of Sterility with Sterile Drug Products by Medaus Pharmacy
    • ACHC Top-Cited Survey Deficiency
    • CMS FAQs about Advance Care Planning as an Optional Element of an Annual Wellness Visit (AWV)
    • CIHQ Requirements for Storage of Medications
    • Class I Recall of Cook Medical’s Central Venous Catheter and Pressure Monitoring Sets and Trays
    • FDA Safety Communication – Do Not Use the OxySure Portable Emergency Oxygen System, Model 615 by OxySure Therapeutics, Inc
    • FDA Offers Five New Unique Device Identification (UDI) Education Modules
    • Recall of B. Braun Medical Inc., 5% Dextrose Injection
    • US Zika Pregnancy Registry
    • Recall of Compounded Products by Reliable Drug Pharmacy
    • TJC Revises PC.01.03.01, EP 6 for Psychiatric Hospitals, Effective April 4, 2016
    • New and Revised Joint Commission National Patient Safety Goal Focusing on Catheter-associated Urinary Tract Infections (CAUTIs)
    • New Drug Safety Communication: FDA Warns about Several Safety Issues with Opioid Pain Medicines and Requires Label Changes
    • HHS Office of Civil Rights Launches Phase 2 of HIPAA Audit Program
    • Recall of Sodium Bicarbonate Injection, USP by Hospira
    • CDC Issues Guideline for Prescribing Opioids for Chronic Pain
    • Patient Safety Hot Topic – Cybersecurity and Medical Devices
    • Class I Recall of Arrow International Inc.’s Intra-Aortic Balloon Catheter Kits and Percutaneous Insertion Kits
    • Class I Recall of GlideScope Titanium Single-Use Video Laryngoscope by Verathon
    • Patient Safety Hot Topic – Discharge Practices
    • Patient Safety Hot Topic – Clostridium difficile
    • Patient Safety Hot Topic – Patient Falls
    • FDA Issues Drug Information Update Clinical Trials with Zydelig (idelalisib) in Combination with other Cancer Medicines
    • Patient Safety Hot Topic – Adverse Drug Events
    • Teleflex Incorporated Announces Worldwide Recall of ARROW International Intra-Aortic Balloon Catheter Kits and Percutaneous Insertion Kits
    • FDA Alerts Health Professionals Not to Use Human and Animal Sterile Drug Products Produced and Distributed by I.V. Specialty, Ltd., Austin, Texas
    • Recall of Teva Pharmaceutical’s Amikacin Sulfate Injection USP, 1 gram per 4mL (250 mg per mL) Vials
    • FDA Letter to Health Care Professionals with Warning about Magnetic Interference between Breast Tissue Expanders with Magnetic Ports and Implantable Cardioverter-defibrillators or Pacemakers
    • OSHA Seeks Comments on Guidance for Determining Potential Health Hazards of Chemicals
    • CMS Releases ICD-10 Assessment Toolkit
    • Recall of Sagent Pharmaceuticals, Inc Fluconazole Injection, USP
    • CDC Vital Signs Report Shows Some Progress but Additional Action Needed to Prevent Health Care Acquired Infections
    • Dräger Evita V500 and Babylog VN500 Ventilators – Recall Expanded to Include Optional PS500 Batteries with New Power Supply Firmware
    • Joint Commission Seeks Comments on Proposed New integrated Care Certification (ICC) Post-Acute Expansion
    • New HIPAA Guidance Reiterates Patients’ Right to Access Health Information and Clarifies Appropriate Fees for Copies
    • CIHQ Requirements for Patient Identification
    • CMS Critical Access Hospital Recertification Checklist for Evaluation of Compliance with the Location and Distance Requirements
    • Abbott Issues Voluntary Safety Notice on MitraClip Delivery System Deployment Process
    • Cook Medical Expands Recall for Beacon Tip Angiographic Catheters to Include Additional Product Lots
    • FDA Safety Communication – Neurosurgical Head Holders (Skull Clamps) Device Slippage
    • Joint Commission Issues Sentinel Event Alert 56 – Detecting and Treating Suicide Ideation in All Settings
    • CDC Issues Health Advisory with Updated Interim Recommendations for the Prevention of Sexual Transmission of Zika Virus
    • CDC Provides Summary of Zika Virus Infection (Zika)
    • FDA Warns Microbial Contamination in Syrspend SF and Syrspend SF Grape Suspending Agents by Fagron
    • Recall of Central Venous Catheters and Pressure Monitoring Sets and Trays by Cook Medical
    • Class I Recall of Oxylog 2000 Plus, 3000, and 3000 Plus Emergency Transport Ventilators by Dräger Medical
    • Unintended Retention of a Foreign Object Once Again Tops Joint Commission List of Most Frequently Reported Sentinel Events
    • FDA’s Automated Endoscope Reprocessors (AERs) Validation Testing
    • CDC Releases 2016 Childhood, Preteen, Teen and Adult Immunization Schedules
    • OSHA Reminds Employers to Post OSHA Form 300A
    • Joint Commission Publishes Prepublication Standards for Opioid Treatment Programs, Effective July 1, 2016
    • Customer Reviews
    • New USP Standard, Hazardous Drugs – Handling in Healthcare Settings, Effective July 1, 2018
    • CDC Interim Guidance for Care and Treatment of Pregnant Women during Zika Virus Outbreak
    • CDC Issues Health Advisory about Increased Influenza Activity
    • Class I Recall of SPOTCHEM II Test Strips by Arkray – Inaccurate Blood Sugar Readings
    • CDC Issues Health Advisory Urging Dialysis Providers and Facilities to Assess and Improve Infection Control Practices to Stop Hepatitis C Virus Transmission in Patients Undergoing Hemodialysis
    • Class I Recall of Thornhill Research Inc., MOVES Ventilator System
    • Recall of Baxter IV Solutions (Select Lots) – Potential for Leaking Containers and Particulate Matter
    • CMS Releases Guide to Preventing Readmissions among Racially and Ethnically Diverse Medicare Beneficiaries
    • Class I Recall of Optisure Dual Coil Defibrillation Leads by St. Jude Medical
    • New Study Raises Concerns about Ambulatory Care Nurses’ Infection Control Practices
    • CDC Adds Countries to Interim Travel Guidance Related to Zika Virus
    • Medical Device Reporting Requirements
    • US Senate Report Finds Fault with Hospitals Reporting Processes during Outbreak of Infections Linked to Medical Scopes
    • CDC Issues Health Advisory about Recognizing, Managing, and Reporting Zika Virus Infections in Travelers Returning from Central America, South America, the Caribbean, and Mexico
    • Recall of Unexpired Sterile Human and Animal Compounded Products by Abbott’s Compounding Pharmacy
    • New TJC Standards for Behavioral Health Care Organizations that Provide Outpatient or Residential Eating Disorder Programs
    • CMA Issues Guidance about Advance Care Planning (ACP) as an Optional Element of an Annual Wellness Visit (AWV)
    • Recall of Children’s Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company – Potential Defect with Dosage Cup
    • OCR Provides Guidance about Individuals’ Core Rights under HIPAA
    • Class I Recall of Pleural and Pneumopericardial Drainage Sets by Stryker Fuhrman
    • Joint Commission Seeks Comment on Draft Performance Measures for Total Hip & Total Knee Replacement
    • Recall of L.G Compounded Asafoetida Powder by Shakti Group – Potential Contamination with Salmonella
    • Second Phase of the Joint Commission’s National Patient Safety Goal (NPSG.06.01.01) is Now Effective
    • Class I Recall of Optional PS500 Batter Power Supply for Evita V500 and Babylog VN500 Ventilators by Dräger
    • Customer Reviews
    • CIHQ Requirements for Medication Orders
    • Recall of Baxter IV Solutions – Potential Presence of Particulate Matter
    • Pharmedium Issues Voluntary Nationwide Recall of 4mg Norepinephrine Bitartrate added to 0.9% Sodium Chloride in 250mL Viaflex Bag and 8mg Norepinephrine Bitartrate added to 0.9% Sodium Chloride in 250mL Viaflex Bag
    • FDA Issues Drug Safety Communication for Noxafil (posaconazole)
    • OSHA Seeks Comments on Updated Version of Voluntary Safety and Health Program Management Guidelines
    • CMS and ONC Issue Request for Information about Certification Frequency and Requirements for Reporting of Quality Measures
    • CMS Infection Control Pilot Project
    • Class I Recall: Etest PIP/TAZO/CON-4 PTC 256 by bioMérieux
    • CMS Finalizes Rule Creating Prior Authorization Process for Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies Items
    • Class I Recall of Boston Scientific Corporation’s Chariot Guiding Sheath
    • Class I Recall of Draeger Perseus A500 Anesthesia Workstation
    • Class I Recall of Insulet Corporation OmniPod Insulin Management System
    • FDA MedWatch – ED-530XT Duodenoscopes by FUJIFILM Medical Systems, U.S.A.: Safety Communication
    • FDA Updates Blood Donor Deferral Policy
    • New OSHA Website on Workplace Violence
    • Joint Commission Releases Prepublication Standards for New, Optional Total Hip and Total Knee Replacement Advanced Certification
    • FDA Eliminates the Risk Evaluation and Mitigation Strategy (REMS) for Rosiglitazone-containing Diabetes Medicines
    • Recall of Chariot Guiding Sheath by Boston Scientific
    • FDA Warns of Potential Contamination with Baclofen Active Pharmaceutical Ingredient from Taizhou Xinyou Pharmaceutical and Chemical
    • CMS Releases Focused Dementia Care Survey Tools
    • CDC Issues Guidance for Vaccine Providers about 2015-2016 Pentacel Manufacturing Delay
    • Class I Recall of Inspiration LS, 5i and 7i Ventilator Systems by eVent Medical
    • CMS Releases Compilation of ICD-10 Resources for Specialties and Selected Health ICD-10 Conditions and Services
    • Joint Commission Seeks Comments on Proposed New Standard on Antimicrobial Stewardship
    • Field Safety Notification for OmniPod Insulin Management System by Insulet
    • Recall of Digital Temple Thermometer (DTT) by K-Jump Health Co., Ltd.
    • Guide to Providing Effective Communication and Language Assistance Services
    • FDA Announces Glades Drugs’ Nationwide Voluntary Recall of Compounded Multivitamins Containing High Amounts of Vitamin D3
    • Class I Recall of Boston Scientific’s RotaWire Elite Guidewire and wireClip Torquer Guidewire
    • CIHQ Requirements for the Management of Radioactive Materials
    • CDC Urges Providers to Counsel Patients about HIV Pre-exposure Prophylaxis
    • FDA Issues Safety Communication for Intravascular Medical Devices
    • Essential Components of a Comprehensive Compliance Plan
    • CMS Issues Advanced Notice of Revised Survey Procedures and Interpretive Guidelines for Laboratories and Laboratory Services
    • FDA Drug Safety Communication about Iodine-containing Contrast Agents for Medical Imaging of Infants
    • FDA Orders Recall under Consent Decree for all Custom Ultrasonics Automated Endoscope Reprocessors
    • Joint Commission Releases 2016 National Patient Safety Goals
    • FDA Offers New MRI Safety Resource
    • Class I Recall of G5 Ventilator by Hamilton – Ventilation and Alarm Failure
    • Get Smart About Antibiotics Week
    • OIG 2016 Work Plan for Nursing Homes and Hospices
    • Office of Inspector General 2016 Work Plan – Medical Equipment and Supplies
    • OIG’s 2016 Work Plan for Hospitals
    • OIG’s 2016 Work Plan for Home Health
    • Comments Sought on Draft Guidance about Minutes of IRB Meetings
    • CDC Issues Challenge to Identify Best Practices for Healthcare-associated Blood Clot Prevention
    • Office of Inspector General Releases 2016 Work Plan
    • Joint Commission Warns that Temporary Names Put Newborns at Risk
    • Recall of Myocardial Protection System (MPS) Delivery Sets by Quest Medical
    • FDA Issues Revised Dispenser Compliance Policy – Extended to March 1, 2016
    • CMS Proposing Revisions to Discharge Planning Requirements
    • CIHQ Medical Record Entry Requirements
    • FDA Updates Drug Safety Communication for Stalevo
    • CDC Issues Health Advisory about Increases in Fentanyl Drug Confiscations and Fentanyl-related Overdose Fatalities
    • Drug Safety Communication for Viekira Pak and Technivie
    • New Apps – Fresh Ideas
    • Dave Gardner
    • Dave Gardner
    • Tech Conference 2015
    • Interview With CEO
    • App’s Update Reaches More Customers
    • New Trends In Responsive Design
    • CDC Launches Improved Online Foodborne Outbreak Search Tool
    • Recall of Downing Labs, LLC Sterile Compounded Products for Lack of Sterility Assurance
    • Dialysis Infection Prevention and Control – Patient Education
    • Preliminary Results of Study into Persistence of Ebola Virus in Body Fluids
    • CDC Study Shows Urgent Need for Improved Controlled Substance Prescribing Practices
    • Reporting Vaccine Adverse Events
    • FDA Issues Safety Communication about Nontuberculous Mycobacterium Infections Associated with Heater-Cooler Devices
    • Cook Medical Expands Global Recall of Select Sizes of Beacon Tip Angiographic Catheters
    • Rapid Diagnostic Testing for Influenza
    • Influenza Vaccine Composition for 2015-2016 U.S. Influenza Season
    • OIG Issues Policy Reminder about Information Blocking and the Federal Anti-Kickback Statute
    • HHS’ OCR New mHealth Platform Aids Developers with HIPAA Questions
    • FDA Notification about Bioprosthetic Aortic Valves
    • FDA’s Drug Supply Chain Security Act Enforcement Date Approaching
    • CDC and FDA Issue Health Update about the Immediate Need for Healthcare Facilities to Review Procedures for Cleaning, Disinfecting, and Sterilizing Medical Devices
    • CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines
    • CDC Ends Enhanced Entry Screening For Travelers from Liberia
    • Joint Commission Issues Sentinel Event Alert #55 – Preventing Falls and Fall-Related Injuries in Health Care Facilities
    • FDA Safety Communication – Cranial Perforators with an Automatic Clutch Mechanism, Failure to Disengage
    • Key Points from the Secure and Responsible Drug Disposal Act of 2010
    • Recall of Sterile Compounded Products by US Compounding, Inc.
    • Joint Commission Removes Life Safety Chapter from their Office Based Surgery Practices Manual – Effective Immediately
    • EPA Proposes Management Standards for Hazardous Waste Pharmaceuticals
    • Tech Magazine Writes About Digital Trends
    • Designing The App Of The Future
    • Tips On Managing Business
    • Tips On Managing Business
    • Katrina Thornton
    • Katrina Thornton
    • FDA Drug Safety Communication about Avycaz (ceftazidime and avibactam)
    • New CDC Antibiotic Stewardship Recommendations for Nursing Homes
    • Class I Recall of SynCardia Systems Freedom Driver System
    • FDA Safety Communication about Infections Associated with Reprocessed Flexible Bronchoscopes
    • Thoratec Issues Voluntary Device Correction
    • FDA Issues Drug Safety Communication for Clozapine
    • AHRQ New Patient Safety Primer – High Reliability
    • Interview With CFO of Fashion Startup
    • Managing Office Culture
    • New Trends In Responsive Design
    • New News App Deliveres Fresh Ideas
    • Class I Recall of Cook Medical’s Beacon Tip Angiographic Catheters – Catheter Tip May Slip or Separate
    • National Cybersecurity Center of Excellence (NCCoE) Seeks Comments on Draft Cybersecurity Practice Guide
    • CMS Memorandum about Medication-Related Adverse Events in Nursing Homes
    • CMS Issues Clarifying Questions and Answers Regarding ICD-10 Flexibilities
    • FDA Drug Safety Communication on Gilenya
    • FDA Safety Communication – Supplemental Measures to Enhance Duodenoscope Reprocessing
    • FDA Safety Communication – Symbiq Infusion System by Hospira: Cybersecurity Vulnerabilities
    • Brintellix (vortioxetine) and Brilinta (ticagrelor) – Name Confusion
    • Hospira Recalling 21 Million Units of Three Injectables
    • CMS Updates Ambulatory Surgical Center (ASC) Infection Control Surveyor Worksheet
    • Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (Fluorouracil Injection, USP)
    • Charlie French
    • Tech Conference 2015
    • Interview With CEO Of Big Data Startup
    • Best Practices for Prevention Slips, Trips and Falls in the Workplace
    • Best Practices for Workplace Violence Prevention
    • FDA Issues Drug Safety Communication for NSAIDs
    • CMS Issues Proposed Physician Fee Schedule for Calendar Year 2016
    • Critical Components of a Safe Patient Handling Program
    • Joint Commission Seeks Input on Two New Proposed Behavioral Health Care Standards
    • FDA Warns Consumers of Risks with Diazepam – Potential of Counterfeit
    • Class I Recall of Teleflex Hudson RCI Lifesaver Single Patient Use Manual Resuscitator
    • Class I Recall of FLOW-i Anesthesia Systems by Maquet
    • FDA Warns of Unapproved Prescription Ear Drop (Otic) Products
    • FDA Drug Safety Communication – Potential Risks of Using Codeine Cough-and-Cold Medicines in Children
    • HHS Launches National Ebola Training and Education Center
    • FDA Announces Delay in Enforcement for Drug Supply Chain Security Act
    • OSHA Adds Key Hazards for Investigators’ Focus during Healthcare Inspections
    • HHS Interactive Online emPOWER Map Available
    • Joint Commission Expands Threshold for Reporting Perinatal Care Measure Set
    • Recall of Covidien Shiley Neonatal and Pediatric Tracheostomy Tubes by Medtronic
    • CDC Health Advisory – Evaluation of Ill Travelers from Liberia to the United States
    • Joseph Turner
    • Interview With CFO of Fashion Startup
    • Class I Recall of M/L Taper with Kinectiv Technology Prosthesis by Zimmer
    • Managing Office Culture
    • International Operation Pangea VIII
    • CDC’s NIOSH Releases Research Findings on N95 Respirator Use by Pregnant Women
    • Class I Recall of HeartWare Ventricular Assist System
    • CMS Issues Guidance for Approval of Home Dialysis Modalities
    • CDC Health Advisory Regarding Updated Information and Guidelines for Evaluation of Patients for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection
    • Joint Commission Seeks Comment on Proposed Comprehensive Cardiac Center Certification Requirements
    • The Joint Commission Revises Hospice Standards, Effective July 1, 2015
    • Mylan is Expanding its Voluntary Nationwide Recall of Select Lots of Injectable Products – Presence of Particulate Matter
    • CMS Releases New Clinical Laboratory Improvement Amendment’s (CLIA) Workbook
    • CDC Issues Health Advisory about Ciprofloxacin- and Azithromycin-Nonsusceptible Shigellosis in the United States
    • Voluntary Recall of Smart Lipo Due to Undeclared Sibutramine, Desmethylsibutramine, and Phenolphthalein
    • Voluntary Recall of Smart Lipo Due to Undeclared Sibutramine, Desmethylsibutramine, and Phenolphthalein
    • Baxter Initiates Voluntary Recall of Select Product Codes of Peripheral Vascular Patch
    • AHRQ Opens Data Submission for Annual Hospital Survey
    • TJC Revised Hospice Standards, Effective July 1, 2015
    • Fiscal Year 2015 HHS OIG Work Plan Mid-Year Update is Released
    • FDA Safety Communication – Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face
    • Recall of Avea Ventilator by CareFusion – Potential Malfunction of Pressure Transducer
    • The Joint Commission – Key Elements of a Fall Reduction Program
    • Tech Magazine Writes About Digital Trends
    • Designing The App Of The Future
    • UX Design Aimed At Millenials
    • Tech Conference 2017
    • Justin Pearson
    • Amanda Mills
    • CHA – Vail, CO – 9/10
    • HAP – Lancaster, PA – 9/9-9/10
    • Leadership Summit – San Francisco, CA – 7/23-7/24
    • CIHQ – Anaheim, CA – 6/10-6/11
    • MCN Learning: Quality of Life

Important Links

Privacy Policy

Disclaimer

Web Accessibility

Site Map

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Copyright 2026 MCN Solutions. All Rights Reserved. Designed by TinyFrog Technologies.